NEW THERAPEUTIC AGENTS

A compound of formula (I) or a compound of formula (II) or pharmaceutically acceptable salts thereof, wherein R1-R7 and X are as defined in the description, and the use of these compounds in therapy, in particular in treating cancer or as an inhibitor of the interaction of the MDM2 protein with p53....

Full description

Saved in:
Bibliographic Details
Main Authors HARDCASTLE IAN, ROBERT, GRIFFIN ROGER JOHN, GOLDING BERNARD, THOMAS, RIEDINGER CHRISTIANE, VALEUR ERIC, WATSON ANNA, FRANCES, NOBLE MARTIN
Format Patent
LanguageEnglish
French
Published 30.12.2009
Online AccessGet full text

Cover

Be the first to leave a comment!
You must be logged in first